BMRA BIOMERICA INC

Overview and Growth

Fiscal 2026 results for BIOMERICA INC combined $4.45M of revenue with net loss of $3.77M and an operating cash outflow of $3.42M. Revenue of $4.45M sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line contracted 16.2% from $5.31M in fiscal 2025; this top-line contraction left the company with a smaller revenue base. Diluted earnings per share were -$1.30, translating the period’s attributable earnings into the amount reported for each diluted share. The diluted weighted-average share count was 2.91M, linking total earnings with the per-share result received by shareholders. Diluted shares moved 26.9% from 2.30M in fiscal 2025, leaving the current share base higher year over year. Total assets stood at $6.76M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. The revenue-to-assets relationship was 0.66x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $362.00K of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 8.1%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced a $5.32M operating loss before non-operating and tax effects. Relative to revenue, the operating deficit measured 119.5%, showing the shortfall after operating costs. The bottom-line result was a net loss of $3.77M after operating, financing, tax, and other recognized items. The net loss equaled 84.8% of revenue, showing the bottom-line deficit relative to the company’s sales base. EBITDA was negative $5.24M, showing a deficit before interest, taxes, depreciation, and amortization. The pretax result was a loss of $3.75M, establishing the deficit before tax effects. Pretax margin was -84.3%, reflecting a pre-tax loss equal to 84.3% of revenue. The company recognized $23.00K of income tax for the period, completing the transition from pretax income to net income. The loss-to-equity relationship was 143.5%, placing the bottom-line deficit against shareholder capital. Relative to total assets, the net loss represented 55.9%. Compared with a $4.97M net loss in fiscal 2025, the current loss improved to $3.77M.

Liquidity and Capital Structure

At period end, the $6.76M asset base was financed through $4.13M of liabilities and $2.63M of equity. Current assets were $4.02M against $2.48M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 1.62x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. The company held $1.31M in cash and equivalents, a narrower liquidity measure than total current assets. Cash and equivalents represented 52.7% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 38.9% of assets, showing the shareholder-capital layer within the company’s balance sheet. Relative to total assets, liabilities measured 61.1%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 19.4%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 13.7% from $5.95M in fiscal 2025, leaving current total assets higher year over year. Reported equity changed 35.9% from $4.11M in fiscal 2025, placing the current capital base lower year over year. Cash and equivalents were 45.5% lower than fiscal 2025 cash of $2.40M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $3.42M, showing that operations absorbed cash during the period. Cash absorbed by operations decreased from $3.84M in fiscal 2025 to $3.42M.

Based on the annual report for the fiscal year ending May 31, 2026. Analysis generated Oct 21, 2026.